Logo

American Heart Association

  116
  0


Final ID:

Targeting triglyceride-rich lipoproteins: Beyond fibrates and fish oils

  • Cariou, Bertrand  ( CHU Nantes , Nantes Cedex 1 , France )
  • Hobbs, Helen  ( HHMI-UT SOUTHWESTERN , Dallas , Texas , United States )
  • Boren, Jan  ( University of Gothenburg , Gothenburg , Sweden )
  • Author Disclosures:
    Bertrand Cariou: DO have relevant financial relationships ; Advisor:Novartis:Active (exists now) ; Advisor:Ultragenyx:Past (completed) ; Speaker:Amgen:Past (completed) ; Advisor:MSD:Active (exists now) ; Advisor:Eli Lilly:Active (exists now) ; Advisor:Novo-Nordisk:Active (exists now) ; Speaker:Astra-Zeneca:Past (completed) ; Speaker:Sanofi:Active (exists now) ; Research Funding (PI or named investigator):Sanofi:Past (completed) | Helen Hobbs: DO NOT have relevant financial relationships | Jan Boren: No Answer
Meeting Info:

Scientific Sessions 2024

2024

Chicago, Illinois

More abstracts on this topic:
More abstracts from these authors:
Long-term Efficacy and Safety of Lerodalcibep in the Open-label 72-week Extension Study of Subjects Previously on Inclisiran or Lerodalcibep in the LIBerate-VI Trial

Asprusten Emil, Licka Manuela, Cariou Bertrand, Vest Jeff, Kallend David, Stein Evan

New Frontiers in Triglyceride Lowering

Tokgozoglu Lale, Remaley Alan T, Cariou Bertrand, Hudgins Lisa

You have to be authorized to contact abstract author. Please, Login
Not Available